Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study
Despite high healthcare costs, nearly half of the patients did not achieve clear/nearly clear skin. These data, in the context of reducing costs for biosimilars, may provide a basis to challenge care pathways and access criteria for 'high-cost' treatments.
Authors
- Joe W. E. Moss (ORCID: https://orcid.org/0000-0002-1866-9752)
- Qin April Neville
- Erin T. Barker (ORCID: https://orcid.org/0000-0001-9031-2312)
- Tejus Dasandi (ORCID: https://orcid.org/0000-0001-7793-2090)
- Elizaveta Gribaleva (ORCID: https://orcid.org/0000-0001-5693-8194)
- Neil Hansell (ORCID: https://orcid.org/0000-0003-3087-6591)
- John Gregory
- C. Smith
- Jonathan N. Barker
- Laura Bojke
- Andrew E. Pink
- Angela Clifford
Institutions
- King's College - North Carolina (US)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Leeds and York Partnership NHS Foundation Trust (GB)
- Thomas Foundation (AU)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1080/09546634.2026.2640305
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00